Presented:

NeoGenomics Completes Acquisition of Genoptix, Inc.

Read Now

Presented:

NeoGenomics Reports 17% Revenue Growth to Record $69 Million

Read Now

Presented:

QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs

Read Now

Presented:

NeoGenomics Signs Definitive Agreement to Acquire Genoptix

Read Now

Presented:

NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018

Read Now

Presented:

NeoGenomics Announces Participation in NCI-MATCH Clinical Trial

Read Now

Presented:

NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier

Read Now

Presented:

NeoGenomics Announces Proposed Public Offering of Common Stock

Read Now

Presented:

NeoGenomics Announces Pricing on Public Offering of Common Stock

Read Now

Presented:

NeoGenomics Announces Proposed Public Offering of Common Stock

Read Now